Matching Contribution

Matching Contribution is a significant feature of an employer-sponsored 401(k) retirement plan, designed to incentivize and assist employees in building their retirement savings. In this context, a Matching Contribution refers to the employer's willingness to contribute funds to an employee's 401(k) account, based on the employee's own contributions. The employer agrees to match a certain percentage or dollar amount of the employee's salary deferral into the 401(k) plan, effectively adding "free money" to the employee's retirement savings.

 

Example 1: 100% Matching Contribution - Let's say an employer offers a dollar-for-dollar match on an employee's contributions, up to 5% of their salary. If the employee contributes 5% of their $50,000 annual salary ($2,500), the employer will also contribute $2,500 to the employee's 401(k) account, doubling the employee's retirement savings.

 

Example 2: Partial Matching Contribution - An employer may offer a partial match, such as 50 cents on the dollar for the first 6% of an employee's salary deferral. If an employee with a $60,000 salary contributes 6% ($3,600) to their 401(k), the employer will contribute 50% of that amount ($1,800).

 

Example 3: Vesting Schedule - Some employers implement a vesting schedule to encourage employee retention. The vesting schedule determines when an employee gains ownership of the employer's matching contributions. For instance, an employee may be 20% vested after one year of service, and their vesting percentage increases gradually until they become fully vested after, say, five years of service. If the employee leaves before becoming fully vested, they might forfeit a portion of the employer's contributions.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.